Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Molecular epigenetics and genetics in neuro-oncology.

Nagarajan RP, Costello JF.

Neurotherapeutics. 2009 Jul;6(3):436-46. doi: 10.1016/j.nurt.2009.04.002. Review.

2.

Epigenetic mechanisms in glioblastoma multiforme.

Nagarajan RP, Costello JF.

Semin Cancer Biol. 2009 Jun;19(3):188-97. doi: 10.1016/j.semcancer.2009.02.005. Epub 2009 Feb 20. Review.

PMID:
19429483
3.

Epigenetic aberrations and therapeutic implications in gliomas.

Natsume A, Kondo Y, Ito M, Motomura K, Wakabayashi T, Yoshida J.

Cancer Sci. 2010 Jun;101(6):1331-6. doi: 10.1111/j.1349-7006.2010.01545.x. Epub 2010 Mar 15. Review.

4.

Gene regulation by methylation.

Mueller WC, von Deimling A.

Recent Results Cancer Res. 2009;171:217-39. doi: 10.1007/978-3-540-31206-2_13. Review.

PMID:
19322547
5.

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.

Gömöri E, Pál J, Kovács B, Dóczi T.

Diagn Pathol. 2012 Jan 20;7:8. doi: 10.1186/1746-1596-7-8.

6.

Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.

Ji W, Yang L, Yu L, Yuan J, Hu D, Zhang W, Yang J, Pang Y, Li W, Lu J, Fu J, Chen J, Lin Z, Chen W, Zhuang Z.

Carcinogenesis. 2008 Jun;29(6):1267-75. doi: 10.1093/carcin/bgn012. Epub 2008 Jan 19.

PMID:
18204074
7.

Predictive biomarkers in adult gliomas: the present and the future.

Thomas L, Di Stefano AL, Ducray F.

Curr Opin Oncol. 2013 Nov;25(6):689-94. doi: 10.1097/CCO.0000000000000002. Review.

PMID:
24076583
8.

Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.

Ramalho-Carvalho J, Pires M, Lisboa S, Graça I, Rocha P, Barros-Silva JD, Savva-Bordalo J, Maurício J, Resende M, Teixeira MR, Honavar M, Henrique R, Jerónimo C.

PLoS One. 2013;8(3):e58206. doi: 10.1371/journal.pone.0058206. Epub 2013 Mar 11.

9.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

10.

Epigenetic changes in gliomas.

Burgess R, Jenkins R, Zhang Z.

Cancer Biol Ther. 2008 Sep;7(9):1326-34. Epub 2008 Sep 18. Review.

11.

Compendium of aberrant DNA methylation and histone modifications in cancer.

Hattori N, Ushijima T.

Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):3-9. doi: 10.1016/j.bbrc.2014.08.140. Epub 2014 Sep 4.

PMID:
25194808
12.
13.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
14.

The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.

Cecener G, Tunca B, Egeli U, Bekar A, Tezcan G, Erturk E, Bayram N, Tolunay S.

Cell Mol Neurobiol. 2012 Mar;32(2):237-44. doi: 10.1007/s10571-011-9753-7. Epub 2011 Sep 18.

PMID:
21928112
15.

Deregulated chromatin remodeling in the pathobiology of brain tumors.

Spyropoulou A, Piperi C, Adamopoulos C, Papavassiliou AG.

Neuromolecular Med. 2013 Mar;15(1):1-24. doi: 10.1007/s12017-012-8205-y. Review.

PMID:
23114751
16.

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre JY.

J Clin Oncol. 2009 Sep 1;27(25):4150-4. doi: 10.1200/JCO.2009.21.9832. Epub 2009 Jul 27.

PMID:
19636000
17.

Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.

Palani M, Devan S, Arunkumar R, Vanisree AJ.

Med Oncol. 2011 Dec;28 Suppl 1:S445-52. doi: 10.1007/s12032-010-9671-4. Epub 2010 Sep 16.

PMID:
20844987
18.

Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.

Malzkorn B, Wolter M, Riemenschneider MJ, Reifenberger G.

Brain Pathol. 2011 Nov;21(6):619-32. doi: 10.1111/j.1750-3639.2011.00536.x. Review.

PMID:
21939466
19.

An Innovative Fluorescent Semi-quantitative Methylation-specific PCR Method for the Determination of MGMT Promoter Methylation is Reflecting Intra-tumor Heterogeneity.

Nguyen A, Legrain M, Noel G, Coca A, Meyer Ea N, Schott R, Lasthaus C, Chenard MP, Gaub MP, Lessinger JM, Guenot D, Entz-Werle N.

Curr Cancer Drug Targets. 2015;15(7):624-40.

PMID:
26118907
20.

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.

Wiestler B, Capper D, Sill M, Jones DT, Hovestadt V, Sturm D, Koelsche C, Bertoni A, Schweizer L, Korshunov A, Weiß EK, Schliesser MG, Radbruch A, Herold-Mende C, Roth P, Unterberg A, Hartmann C, Pietsch T, Reifenberger G, Lichter P, Radlwimmer B, Platten M, Pfister SM, von Deimling A, Weller M, Wick W.

Acta Neuropathol. 2014 Oct;128(4):561-71. doi: 10.1007/s00401-014-1315-x. Epub 2014 Jul 10.

PMID:
25008768

Supplemental Content

Support Center